Patents by Inventor Scott Aesif

Scott Aesif has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS
    Publication number: 20140140975
    Abstract: The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, airway inflammation or asthma. In some embodiments, a glutaredoxin may be used to treat a subject. Also provided in certain aspects of the present invention are kits for therapies involving glutaredoxins, methods for promoting such therapies, and the like.
    Type: Application
    Filed: November 12, 2013
    Publication date: May 22, 2014
    Applicants: Universiteit Maastricht, The University of Vermont and State Agricultural College
    Inventors: Yvonne M. Janssen-Heininger, Niki Reynaert, Vikas Anathy, Scott Aesif
  • Treatments involving glutaredoxins and similar agents
    Patent number: 8679811
    Abstract: The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, airway inflammation or asthma. In some embodiments, a glutaredoxin may be used to treat a subject. Also provided in certain aspects of the present invention are kits for therapies involving glutaredoxins, methods for promoting such therapies, and the like.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: March 25, 2014
    Assignees: The University of Vermont and State Agricultural College, Universiteit Maastricht
    Inventors: Yvonne M. Janssen-Heininger, Niki Lea Reynaert, Vikas Anathy, Scott Aesif
  • TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS
    Publication number: 20100266566
    Abstract: The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, airway inflammation or asthma. In some embodiments, a glutaredoxin may be used to treat a subject. Also provided in certain aspects of the present invention are kits for therapies involving glutaredoxins, methods for promoting such therapies, and the like.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 21, 2010
    Inventors: Yvonne M. Janssen-Heininger, Niki Lea Reynaert, Vikas Anathy, Scott Aesif